These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37173266)

  • 1. Building global vaccine manufacturing capacity: Spotlight on Africa.
    Rubin Thompson LJ; Grubo M; Veller M; Badenhorst RH; Nott J; Debruyne L; Makadzange T; Nicolaou S; Stanberry L; Sall A; James WG
    Vaccine; 2023 Jun; 41(27):4050-4056. PubMed ID: 37173266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.
    Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA
    Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.
    Akegbe H; Onyeaka H; Michael Mazi I; Alex Olowolafe O; Dolapo Omotosho A; Olatunji Oladunjoye I; Amuda Tajudeen Y; Seun Ofeh A
    Vaccine X; 2023 Aug; 14():100320. PubMed ID: 37293248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.
    Bright B; Babalola CP; Sam-Agudu NA; Onyeaghala AA; Olatunji A; Aduh U; Sobande PO; Crowell TA; Tebeje YK; Phillip S; Ndembi N; Folayan MO
    Global Health; 2021 Mar; 17(1):24. PubMed ID: 33658050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A call to action: securing an uninterrupted supply of Africa's medical products and technologies post COVID-19.
    Ejekam CS; Emeje M; Lukulay P; Uche CR; Odibeli O; Sanusi O; Anyakora C
    J Public Health Policy; 2023 Jun; 44(2):276-284. PubMed ID: 36997622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction.
    Makenga G; Bonoli S; Montomoli E; Carrier T; Auerbach J
    Front Public Health; 2019; 7():56. PubMed ID: 30949465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors, enablers and challenges for COVID-19 vaccine development.
    Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building the Momentum for A Stronger Pharmaceutical System in Africa.
    Ussai S; Chillotti C; Stochino E; Deidda A; Ambu G; Anania L; Boccalini A; Colombo F; Ferrari A; Pala D; Puddu E; Rapallo G; Pistis M
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 experience in Africa and the Middle East.
    Bizri AR; Al Akoury N; Mhlanga T; Morales GDC; Haridy H; Hussey GD; Srivastava A
    Ann Med; 2023 Dec; 55(1):2222641. PubMed ID: 37345635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
    Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
    Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.
    Govender K; Nyamaruze P; McKerrow N; Meyer-Weitz A; Cowden RG
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35153193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccinology landscape in Africa.
    Baptista S; Naidoo S; Suliman S; Nepolo E; Kanoi BN; Gitaka J; Blessing OM; Enany S
    Front Immunol; 2022; 13():955168. PubMed ID: 36544758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines and vaccination: how prepared is Africa?
    Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F
    Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P;
    Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing COVID-19 vaccine hesitancy in South Africa- moving beyond a reliance on information-based responses.
    Cooper S; van Rooyen H; Wiysonge CS
    Hum Vaccin Immunother; 2022 Nov; 18(6):2107851. PubMed ID: 35993844
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.